• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

爱尔兰多囊肾病的基因图谱。

The genetic landscape of polycystic kidney disease in Ireland.

作者信息

Benson Katherine A, Murray Susan L, Senum Sarah R, Elhassan Elhussein, Conlon Eoin T, Kennedy Claire, Conlon Shane, Gilbert Edmund, Connaughton Dervla, O'Hara Paul, Khamis Sarah, Cormican Sarah, Brody Lawrence C, Molloy Anne M, Lynch Sally Ann, Casserly Liam, Griffin Matthew D, Carton Robert, Yachnin Kevin, Harris Peter C, Cavalleri Gianpiero L, Conlon Peter

机构信息

School of Pharmacy and Biomolecular Science, Royal College of Surgeons in Ireland, Dublin, Ireland.

Department of Nephrology, Beaumont Hospital, Dublin, Ireland.

出版信息

Eur J Hum Genet. 2021 May;29(5):827-838. doi: 10.1038/s41431-020-00806-5. Epub 2021 Jan 16.

DOI:10.1038/s41431-020-00806-5
PMID:33454723
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8110806/
Abstract

Polycystic kidney diseases (PKDs) comprise the most common Mendelian forms of renal disease. It is characterised by the development of fluid-filled renal cysts, causing progressive loss of kidney function, culminating in the need for renal replacement therapy or kidney transplant. Ireland represents a valuable region for the genetic study of PKD, as family sizes are traditionally large and the population relatively homogenous. Studying a cohort of 169 patients, we describe the genetic landscape of PKD in Ireland for the first time, compare the clinical features of patients with and without a molecular diagnosis and correlate disease severity with autosomal dominant pathogenic variant type. Using a combination of molecular genetic tools, including targeted next-generation sequencing, we report diagnostic rates of 71-83% in Irish PKD patients, depending on which variant classification guidelines are used (ACMG or Mayo clinic respectively). We have catalogued a spectrum of Irish autosomal dominant PKD pathogenic variants including 36 novel variants. We illustrate how apparently unrelated individuals carrying the same autosomal dominant pathogenic variant are highly likely to have inherited that variant from a common ancestor. We highlight issues surrounding the implementation of the ACMG guidelines for variant pathogenicity interpretation in PKD, which have important implications for clinical genetics.

摘要

多囊肾病(PKD)是最常见的孟德尔遗传性肾病类型。其特征是出现充满液体的肾囊肿,导致肾功能逐渐丧失,最终需要进行肾脏替代治疗或肾移植。爱尔兰是进行PKD基因研究的一个重要地区,因为传统上家庭规模较大且人口相对同质。通过对169名患者的队列研究,我们首次描述了爱尔兰PKD的基因图谱,比较了有分子诊断和无分子诊断患者的临床特征,并将疾病严重程度与常染色体显性致病变异型相关联。使用包括靶向二代测序在内的多种分子遗传学工具,根据所使用的变异分类指南(分别为美国医学遗传学与基因组学学会(ACMG)或梅奥诊所指南),我们报告爱尔兰PKD患者的诊断率为71% - 83%。我们已梳理出一系列爱尔兰常染色体显性PKD致病变异,包括36种新变异。我们说明了携带相同常染色体显性致病变异的明显无关个体如何极有可能从共同祖先那里继承了该变异。我们强调了在PKD中实施ACMG变异致病性解读指南所涉及的问题,这些问题对临床遗传学具有重要意义。

相似文献

1
The genetic landscape of polycystic kidney disease in Ireland.爱尔兰多囊肾病的基因图谱。
Eur J Hum Genet. 2021 May;29(5):827-838. doi: 10.1038/s41431-020-00806-5. Epub 2021 Jan 16.
2
Identifying gene mutations of Chinese patients with polycystic kidney disease through targeted next-generation sequencing technology.通过靶向下一代测序技术鉴定中国多囊肾病患者的基因突变。
Mol Genet Genomic Med. 2019 Jun;7(6):e720. doi: 10.1002/mgg3.720. Epub 2019 May 6.
3
Pathogenicity analysis of novel variations in Chinese Han patients with polycystic kidney disease.中国汉族多囊肾病患者新变异的致病性分析
Gene. 2017 Aug 30;626:433-441. doi: 10.1016/j.gene.2017.05.046. Epub 2017 Jun 1.
4
Optimising the management of polycystic kidney disease.优化多囊肾病的管理
Practitioner. 2016 Feb;260(1790):13-6, 2.
5
Disease causing property analyzation of variants in 12 Chinese families with polycystic kidney disease.12 个多囊肾病家系变异的致病特性分析。
Mol Genet Genomic Med. 2020 Nov;8(11):e1467. doi: 10.1002/mgg3.1467. Epub 2020 Sep 24.
6
Molecular analysis of a consanguineous Iranian polycystic kidney disease family identifies a PKD2 mutation that aids diagnostics.对一个伊朗近亲多囊肾病家族的分子分析确定了一种有助于诊断的PKD2突变。
BMC Nephrol. 2013 Sep 8;14:190. doi: 10.1186/1471-2369-14-190.
7
Experimental Models of Polycystic Kidney Disease: Applications and Therapeutic Testing.多囊肾病的实验模型:应用和治疗测试。
Kidney360. 2023 Aug 1;4(8):1155-1173. doi: 10.34067/KID.0000000000000209. Epub 2023 Jul 7.
8
Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.单等位基因 IFT140 致病性变异是常染色体显性多囊肾病谱表型的一个重要原因。
Am J Hum Genet. 2022 Jan 6;109(1):136-156. doi: 10.1016/j.ajhg.2021.11.016. Epub 2021 Dec 9.
9
[Clinical practice guidelines for polycystic kidney diseases].[多囊肾病临床实践指南]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020 Mar 10;37(3):277-283. doi: 10.3760/cma.j.issn.1003-9406.2020.03.009.
10
Kidney: polycystic kidney disease.肾脏:多囊肾病。
Wiley Interdiscip Rev Dev Biol. 2014 Nov-Dec;3(6):465-87. doi: 10.1002/wdev.152. Epub 2014 Sep 3.

引用本文的文献

1
Characterization of Monogenic Kidney Disease in Older Patients With CKD.老年慢性肾脏病患者单基因肾病的特征分析
Kidney Int Rep. 2025 Apr 22;10(7):2140-2152. doi: 10.1016/j.ekir.2025.04.017. eCollection 2025 Jul.
2
Genetic and protein structure prediction analyses identify a rare pathogenic PKD1 variant causing autosomal dominant polycystic kidney disease.基因和蛋白质结构预测分析鉴定出一种导致常染色体显性多囊肾病的罕见致病性PKD1变异。
CEN Case Rep. 2025 Mar 14. doi: 10.1007/s13730-025-00985-4.
3
The impact of a secondary, rare, non-pathogenic PKD1 variant on disease progression in autosomal dominant polycystic kidney disease.一种继发性、罕见、非致病性PKD1变异对常染色体显性多囊肾病疾病进展的影响。
J Nephrol. 2025 Jan 30. doi: 10.1007/s40620-025-02211-x.
4
Phenotypic outcomes of PKD1 compared with non-PKD1 genetically confirmed autosomal dominant polycystic kidney disease.与经基因确认的非PKD1型常染色体显性多囊肾病相比,PKD1的表型结果。
J Nephrol. 2025 Jan 30. doi: 10.1007/s40620-024-02184-3.
5
Utility of Genetic Testing in Adults with CKD: A Systematic Review and Meta-Analysis.成人慢性肾脏病基因检测的效用:一项系统评价与荟萃分析
Clin J Am Soc Nephrol. 2025 Jan 1;20(1):101-115. doi: 10.2215/CJN.0000000000000564. Epub 2024 Sep 19.
6
A Novel Monoallelic Variant Causing Late-Onset ADPKD and Tubulointerstitial Fibrosis.一种导致迟发性常染色体显性多囊肾病和肾小管间质纤维化的新型单等位基因变异
Kidney Int Rep. 2024 Apr 15;9(7):2209-2226. doi: 10.1016/j.ekir.2024.04.031. eCollection 2024 Jul.
7
Familial Variability of Disease Severity in Adult Patients With ADPKD.成人常染色体显性多囊肾病患者疾病严重程度的家族变异性
Kidney Int Rep. 2023 Dec 12;9(3):649-660. doi: 10.1016/j.ekir.2023.12.002. eCollection 2024 Mar.
8
Monoallelic pathogenic variants are a common cause of autosomal dominant polycystic kidney disease-spectrum phenotype.单等位基因致病性变异是常染色体显性多囊肾病谱系表型的常见病因。
Clin Kidney J. 2024 Feb 15;17(2):sfae026. doi: 10.1093/ckj/sfae026. eCollection 2024 Feb.
9
PKD1 Truncating Mutations Accelerate eGFR Decline in Autosomal Dominant Polycystic Kidney Disease Patients.PKD1 截断突变加速常染色体显性多囊肾病患者的 eGFR 下降。
Am J Nephrol. 2024;55(3):380-388. doi: 10.1159/000536165. Epub 2024 Jan 9.
10
Copy Number Variations in Hereditary Spastic Paraplegia-Related Genes: Evaluation of an Iranian Hereditary Spastic Paraplegia Cohort and Literature Review.遗传性痉挛性截瘫相关基因的拷贝数变异:伊朗遗传性痉挛性截瘫队列评估及文献综述
Mol Syndromol. 2023 Dec;14(6):477-484. doi: 10.1159/000531507. Epub 2023 Jul 7.